In vivo characterization of PD-L1 expression in breast cancer by immuno-PET with (89)Zr-labeled avelumab

Programmed death protein 1 and programmed death-ligand 1 (PD-1/PD-L1) have been widely studied as one of the most critical immune check-point pairs in the cancer microenvironment. In breast cancer (BrCa), the expression of PD-L1 is regarded as a determinant biomarker for patient stratification and p...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Am J Transl Res
Asıl Yazarlar: Li, Miao, Ehlerding, Emily B, Jiang, Dawei, Barnhart, Todd E, Chen, Weiyu, Cao, Tianye, Engle, Jonathan W, Cai, Weibo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: e-Century Publishing Corporation 2020
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7270013/
https://ncbi.nlm.nih.gov/pubmed/32509182
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller